Catalog

Guidelines and Review of Tricuspid and Interatrial Septum/LAA Imaging Protocols
Online
Added:12/17/2021 2:59 PM

This webinar, hosted by Dr. Rebecca Hahn, will focus on the new Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention guideline. The guideline is intended for the Level II or III echocardiographer whose pre-procedural imaging becomes the backbone of structural heart disease (SHD) procedural planning for the heart team. The structured imaging acquisition protocols and extensive figures and tables show examples of the protocols and should benefit all echocardiographers involved in the care of SHD patients. This second session will focus on the Guidelines and Review of Tricuspid and Interatrial Septum/LAA Imaging Protocols.
CME Information: 1.0 AMA PRA Category 1 CreditsTM
Release Date: December 2021
Activity Expiration Date: December 20, 2024 - CME/MOC must be claimed by this date
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded
$0.00
Already successfully completed: re-enrollment available!
Secure Transaction

Recently Added Items

About this item

This webinar, hosted by Dr. Rebecca Hahn, will focus on the new Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention guideline. The guideline is intended for the Level II or III echocardiographer whose pre-procedural imaging becomes the backbone of structural heart disease (SHD) procedural planning for the heart team. The structured imaging acquisition protocols and extensive figures and tables show examples of the protocols and should benefit all echocardiographers involved in the care of SHD patients. This second session will focus on the Guidelines and Review of Tricuspid and Interatrial Septum/LAA Imaging Protocols.

CME Information: 1.0 AMA PRA Category 1 CreditsTM

Release Date: December 2021

Activity Expiration Date: December 20, 2024 - CME/MOC must be claimed by this date

Course/Activity Information

Target Audience: This activity is designed for all cardiovascular sonographers and physicians with a primary interest and knowledge base in the field of cardiovascular imaging.

Learning Objectives:

  1. Review the anatomy of the d tricuspid valve and interatrial septum/LAA
  2. Understand the essential imaging views and hemodynamic assessment required to perform a comprehensive evaluation of tricuspid valve function.
  3. Understand the essential imaging views and hemodynamic assessment required to perform a comprehensive evaluation of the interatrial septum and left atrial appendage

Accreditation Statement:

The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this article for a maximum of AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program and/or the American Board of Anesthesiology’s (ABA) Maintenance of Certification in Anesthesiology Program® or MOCA 2.0®. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points and/or ABA MOCA 2.0®.   Physicians will earn MOC and/or MOCA 2.0 points equivalent to the amount of CME credits claimed for the activity.

ARDMS, CCI, Sonography Canada recognize ASE’s certificates and have agreed to honor the credit hours toward their registry requirements for sonographers.

Disclosures: 

According to ACCME policy, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies, and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity.

Dr. Hahn has the following financial relationships with ineligible companies to disclose:

  • Edwards Lifescience (Speaker's Bureau, Scientific Advisory Board)
  • Abbott Vascular (Scientific Advisory Board)
  • Boston Scientific (Scientific Advisory Board)
  • Philips Healthcare (Speaker's Bureau, Scientific Advisory Board)
  • Gore & Associates (Scientific Advisory Board)
  • Medtronic (Scientific Advisory Board

 

Other information

  • Training Hours: 1.00
  • Additional Charges May Apply

    Ratings and reviews

    Close
    Shopping Cart
    Total:  Close

    Loading Shopping Cart Items...